Sunshine Biopharma Inc. Interest Expense Nonoperating
Sunshine Biopharma Inc. (SBFM) reported Interest Expense Nonoperating of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-03.
Financial Statements › Expense Statement
us-gaap:InterestExpenseNonoperating · last filed 2026-04-03
- Sunshine Biopharma Inc. interest expense nonoperating for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $0.00.
- Sunshine Biopharma Inc. interest expense nonoperating for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. interest expense nonoperating for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. interest expense nonoperating for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Sunshine Biopharma Inc. interest expense nonoperating for fiscal 2024 was $8.77K, a 93.61% decline from fiscal 2023.
- Sunshine Biopharma Inc. interest expense nonoperating for fiscal 2023 was $137.31K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $0.00 derived: sum of 2 quarters · filed 2026-04-03 | $0.00 derived: sum of 3 quarters · filed 2026-04-03 | $0.00 10-K · filed 2026-04-03 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $8.53K derived: sum of 4 quarters · filed 2026-04-03 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $8.53K derived: sum of 3 quarters · filed 2026-04-03 | $8.53K derived: sum of 4 quarters · filed 2026-04-03 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $8.53K derived: sum of 2 quarters · filed 2026-04-03 | $8.53K derived: sum of 3 quarters · filed 2026-04-03 | $8.77K derived: sum of 4 quarters · filed 2026-04-03 |
| 2024-12-31 | $8.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-03 | $8.53K derived: sum of 2 quarters · filed 2026-04-03 | $8.77K derived: sum of 3 quarters · filed 2026-04-03 | $8.77K 10-K · filed 2026-04-03 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $245.00 derived: sum of 2 quarters · filed 2025-11-13 | $245.00 10-Q · filed 2025-11-13 | $79.54K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $245.00 10-Q · filed 2025-08-12 | $245.00 10-Q · filed 2025-08-12 | $79.54K derived: sum of 3 quarters · filed 2025-08-12 | $118.06K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $49.18K 10-Q · filed 2025-05-15 | $79.29K derived: sum of 2 quarters · filed 2025-05-15 | $117.82K derived: sum of 3 quarters · filed 2025-05-15 | $121.15K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $30.11K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $68.64K derived: sum of 2 quarters · filed 2025-04-01 | $71.97K derived: sum of 3 quarters · filed 2025-04-01 | $137.31K 10-K · filed 2025-04-01 |
| 2023-09-30 | $38.53K 10-Q · filed 2024-11-05 | $41.86K derived: sum of 2 quarters · filed 2024-11-05 | $107.20K 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $3.33K 10-Q/A · filed 2024-08-20 | $7.75K 10-Q/A · filed 2024-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |